Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV
The Journal of Infectious Diseases · 14.11.2025 · 232 (5) · 1067-1077
DOI: 10.1093/infdis/jiaf430 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 14.08.2025. Verfasst von Lishomwa C Ndhlovu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: HIV Infections, Dendritic Cells, HIV-1, Anti-HIV Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, NIAID NIH HHS, Fundação de Apoio à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Background
Except for hematopoietic cell transplantation, therapeutic-driven HIV-1 curative approaches have been unsuccessful. Here, we describe a 2-step randomized clinical trial designed to evaluate the safety and impact of individual and combinatorial therapeutic strategies on changes in peripheral and gut mucosal HIV reservoirs, immune activation and function in people with HIV with chronic disease and high CD4 T-cell nadirs.
Methods
Thirty participants were enrolled and randomized equally into 6 study arms based on treatments with either standard antiretroviral therapy (ART) alone or a combination of candidate anti-HIV reservoir strategies that included ART intensification, auranofin (an apoptotic-inducer antirheumatic drug), nicotinamide (vitamin B3), and a personalized dendritic cell therapy.
Results
After an analytical treatment interruption post intervention, all eligible participants rebounded within 14 weeks, except for 1 participant with rebound detected at 84 weeks and 2 participants receiving all combined therapies maintained viral loads below 1000 copies/mL through the study period. These posttreatment controllers all received nicotinamide containing regimens and exhibited immune cellular epigenetic age reversal.
Conclusions
This proof-of-concept clinical trial demonstrates the safety of multiple interventions with distinct antireservoir activities in people with HIV and argues for continued investigation of both single and combinatorial interventions towards posttherapy HIV control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.
- Laboratório de Retrovirologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.
- Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
- Departamento de Doenças Infecciosas e Parasitárias, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Department of Infectious Diseases, Italian Institute of Health, Rome, Italy.
ORCID-Profile: Lishomwa C Ndhlovu, Leila B Giron, Thomas A Premeaux, Alina P S Pang, Danilo Dias, Marcella Vassão de Almeida Baptista, Iart Luca Shytaj, Michael J Corley, Scott A Bowler, Maria Cecilia Sucupira, James R Hunter, Ricardo Sobhie Diaz
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- NIAID NIH HHS
- Fundação de Apoio à Pesquisa do Estado de São Paulo
- NIH HHS
- ViiV Healthcare Investigator Sponsored Study
- National Institutes of Health
Zitieren
APA
Ndhlovu, L. C., Giron, L. B., Galinskas, J., Premeaux, T. A., Pang, A. P. S., Dias, D., de Almeida Baptista, M. V., Shytaj, I. L., Maricato, J. T., Ferreira, P. R. A., Gosuen, G., Corley, M. J., Friday, C. M., Bowler, S. A., Della Libera, E., Sucupira, M. C., Hunter, J. R., Janini, L. M., Schechter, M., …, & SPARC Working Group (2025). Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV. The Journal of Infectious Diseases, 232(5), 1067-1077. https://doi.org/10.1093/infdis/jiaf430
Vancouver
Ndhlovu LC, Giron LB, Galinskas J, Premeaux TA, Pang APS, Dias D, et al. Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV. The Journal of Infectious Diseases. 2025;232(5):1067-1077. doi:10.1093/infdis/jiaf430
BibTeX
@article{Ndhlovu2025,
author = {Ndhlovu, Lishomwa C and Giron, Leila B and Galinskas, Juliana and Premeaux, Thomas A and Pang, Alina P S and Dias, Danilo and de Almeida Baptista, Marcella Vassão and Shytaj, Iart Luca and Maricato, Juliana T and Ferreira, Paulo R A and Gosuen, Gisele and Corley, Michael J and Friday, Courtney M and Bowler, Scott A and Della Libera, Ermelindo and Sucupira, Maria Cecilia and Hunter, James R and Janini, Luis Mário and Schechter, Mauro and Savarino, Andrea and Diaz, Ricardo Sobhie and SPARC Working Group, SPARC Working Group},
title = {Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {232},
number = {5},
pages = {1067--1077},
doi = {10.1093/infdis/jiaf430}
}
EUVIMED